Jw Pharmac (001060) — Working Capital to Net Assets Ratio
Jw Pharmac (001060) has a Working Capital to Net Assets ratio of 25.5% as of March 2026. Working capital of ₩97.54 Billion (current assets of ₩308.90 Billion minus current liabilities of ₩211.35 Billion) is measured against net assets of ₩381.78 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 001060 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Jw Pharmac Working Capital to Net Assets (2013–2025)
This chart shows how Jw Pharmac's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 25.5%, reflecting working capital of ₩97.54 Billion against net assets of ₩381.78 Billion KRW. For the complete balance sheet picture, see Jw Pharmac (001060) total assets.
Annual Working Capital to Net Assets for Jw Pharmac (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Jw Pharmac from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Jw Pharmac (001060) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 23.6% | ₩87.35 Billion | ₩369.37 Billion | ₩296.51 Billion | ₩209.16 Billion | ▼ -6.0 pp |
| 2024 | 29.7% | ₩97.80 Billion | ₩329.49 Billion | ₩306.41 Billion | ₩208.62 Billion | ▼ -4.7 pp |
| 2023 | 34.3% | ₩91.16 Billion | ₩265.44 Billion | ₩378.09 Billion | ₩286.93 Billion | ▲ +14.3 pp |
| 2022 | 20.1% | ₩45.33 Billion | ₩225.76 Billion | ₩425.46 Billion | ₩380.13 Billion | ▼ -24.4 pp |
| 2021 | 44.4% | ₩83.77 Billion | ₩188.54 Billion | ₩366.45 Billion | ₩282.68 Billion | ▲ +13.3 pp |
| 2020 | 31.1% | ₩64.58 Billion | ₩207.47 Billion | ₩299.33 Billion | ₩234.75 Billion | ▲ +6.3 pp |
| 2019 | 24.8% | ₩57.07 Billion | ₩230.09 Billion | ₩335.06 Billion | ₩277.98 Billion | ▼ -31.1 pp |
| 2018 | 56.0% | ₩145.54 Billion | ₩260.11 Billion | ₩373.91 Billion | ₩228.37 Billion | ▲ +5.4 pp |
| 2017 | 50.5% | ₩136.83 Billion | ₩270.78 Billion | ₩411.37 Billion | ₩274.54 Billion | ▼ -9.1 pp |
| 2016 | 59.6% | ₩164.67 Billion | ₩276.31 Billion | ₩422.64 Billion | ₩257.98 Billion | ▲ +8.4 pp |
| 2015 | 51.2% | ₩115.39 Billion | ₩225.41 Billion | ₩376.17 Billion | ₩260.78 Billion | ▼ -7.8 pp |
| 2014 | 59.0% | ₩132.06 Billion | ₩223.83 Billion | ₩343.50 Billion | ₩211.44 Billion | ▲ +55.1 pp |
| 2013 | 3.9% | ₩7.82 Billion | ₩200.74 Billion | ₩324.09 Billion | ₩316.28 Billion | — |